This year, several state legislatures will consider bills to establish vapor product directories. Amid heightened scrutiny of illicit vapor products by the U.S. Food and Drug Administration (FDA), these product directory bills would create a mechanism for states to bar the sale of products that are not FDA-authorized or subject to a pending premarket application. Like state cigarette directories implemented in connection with the tobacco Master Settlement Agreement, these directories would specify which vapor products are permitted to be sold in the state.

Only three states currently have vapor product directories, including Alabama (with respect to “e-liquids” and “alternative nicotine products”), Louisiana (with respect to “vapor products” and “alternative nicotine products”), and Oklahoma (with respect to “vapor products”). In January, legislatures in Florida, Indiana, Missouri, and Virginia introduced bills to establish their own vapor product directories.

The recently introduced bills are aimed at reducing the proliferation of illicit vapor products and have the following elements:

  • A state administrative agency (typically the Department of Revenue, Office of the Attorney General, or alcoholic beverage authority) maintains a directory of vapor products permitted to be sold in the state, listed by brand and manufacturer. The responsible agency must publish and maintain the directory on its public website.
  • Products not listed in the directory may not be sold in the state—whether by manufacturers, wholesalers, or retailers. The appropriate state agencies are authorized to take enforcement action against those dealing in noncompliant products.
  • Manufacturers seeking to have their vapor products listed must file a certification for each product—affirming that their product is either the subject of an FDA marketing granted order or a premarket tobacco product application filed prior to September 9, 2020, which remains under consideration. Under the bills introduced in Indiana, Missouri, and Virginia, manufacturers must pay an initial filing fee and an annually recurring fee for each product sought to be listed.

Beyond garnering attention from state legislatures, illicit vapor products are increasingly in federal regulators’ crosshairs. As we recently reported, the FDA concluded 2023 with multiple rounds of enforcement action against sellers of illegal vapor products, including warning letters and civil money penalty complaints. We expect this pattern of federal enforcement to continue, regardless of state-level action.

It remains to be seen whether the state directory regimes, as proposed, will curb the prevalence of unauthorized products. However, these bills may signal a broader shift in the overall tobacco and nicotine regulatory environment—one in which FDA is no longer the only regulator patrolling the block for illicit vapor products. We will continue monitoring the introduction of state vapor product directory bills around the country, as more states may consider similar initiatives.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Bryan Haynes Bryan Haynes

Bryan Haynes serves clients by developing and implementing creative solutions for complex issues. Specializing in tobacco industry regulatory compliance and enforcement matters, Bryan efficiently assists clients in complying with regulatory obligations and managing risk, consistent with clients’ business objectives.

Photo of Agustin Rodriguez Agustin Rodriguez

Agustin is sought after by clients for his strategic counsel on their most challenging competitive and regulatory compliance issues, including tobacco Master Settlement Agreement issues, federal and state enforcement investigations, licensing and excise tax issues, developing compliance programs, and evaluating advertising and marketing…

Agustin is sought after by clients for his strategic counsel on their most challenging competitive and regulatory compliance issues, including tobacco Master Settlement Agreement issues, federal and state enforcement investigations, licensing and excise tax issues, developing compliance programs, and evaluating advertising and marketing practices. A partner in the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group as well as its Tobacco and Cannabis law practices, he represents manufacturers, distributors, retailers, and suppliers in all aspects of their businesses, including regulatory compliance, FDA requirements, administrative disputes involving federal or state governmental entities, mergers and acquisitions, commercial agreements, and taxation matters.

Photo of Zie Alere Zie Alere

Zie is an associate in the firm’s Regulatory Investigations, Strategy + Enforcement Practice Group. He assists in developing effective strategies to help deter or mitigate the risk of enforcement actions and litigation. As a summer associate, Zie drafted compliance guidelines, worked on pro…

Zie is an associate in the firm’s Regulatory Investigations, Strategy + Enforcement Practice Group. He assists in developing effective strategies to help deter or mitigate the risk of enforcement actions and litigation. As a summer associate, Zie drafted compliance guidelines, worked on pro bono matters, and created analytical memoranda.